1. Home
  2. CSBR vs GAUZ Comparison

CSBR vs GAUZ Comparison

Compare CSBR & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • GAUZ
  • Stock Information
  • Founded
  • CSBR 1985
  • GAUZ 2009
  • Country
  • CSBR United States
  • GAUZ Israel
  • Employees
  • CSBR N/A
  • GAUZ N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • GAUZ Industrial Machinery/Components
  • Sector
  • CSBR Health Care
  • GAUZ Miscellaneous
  • Exchange
  • CSBR Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • CSBR 90.0M
  • GAUZ 102.0M
  • IPO Year
  • CSBR 1986
  • GAUZ 2024
  • Fundamental
  • Price
  • CSBR $6.53
  • GAUZ $2.40
  • Analyst Decision
  • CSBR Strong Buy
  • GAUZ Strong Buy
  • Analyst Count
  • CSBR 1
  • GAUZ 2
  • Target Price
  • CSBR $12.00
  • GAUZ $11.50
  • AVG Volume (30 Days)
  • CSBR 10.6K
  • GAUZ 218.9K
  • Earning Date
  • CSBR 12-12-2025
  • GAUZ 11-13-2025
  • Dividend Yield
  • CSBR N/A
  • GAUZ N/A
  • EPS Growth
  • CSBR N/A
  • GAUZ N/A
  • EPS
  • CSBR 0.21
  • GAUZ N/A
  • Revenue
  • CSBR $56,878,000.00
  • GAUZ $96,810,000.00
  • Revenue This Year
  • CSBR $7.31
  • GAUZ $22.59
  • Revenue Next Year
  • CSBR $12.01
  • GAUZ $41.48
  • P/E Ratio
  • CSBR $30.46
  • GAUZ N/A
  • Revenue Growth
  • CSBR 10.11
  • GAUZ 7.87
  • 52 Week Low
  • CSBR $4.07
  • GAUZ $1.52
  • 52 Week High
  • CSBR $11.99
  • GAUZ $13.00
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 39.54
  • GAUZ 33.27
  • Support Level
  • CSBR $6.67
  • GAUZ $1.52
  • Resistance Level
  • CSBR $6.85
  • GAUZ $2.17
  • Average True Range (ATR)
  • CSBR 0.17
  • GAUZ 0.49
  • MACD
  • CSBR -0.05
  • GAUZ -0.06
  • Stochastic Oscillator
  • CSBR 1.79
  • GAUZ 25.29

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

Share on Social Networks: